These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy. Järvilehto J; Harjuhaahto S; Palu E; Auranen M; Kvist J; Zetterberg H; Koskivuori J; Lehtonen M; Saukkonen AM; Jokela M; Ylikallio E; Tyynismaa H Front Neurol; 2022; 13():793937. PubMed ID: 35250809 [TBL] [Abstract][Full Text] [Related]
3. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases. Davis RL; Liang C; Sue CM Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684 [TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265 [TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296 [TBL] [Abstract][Full Text] [Related]
6. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153 [TBL] [Abstract][Full Text] [Related]
7. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders. Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687 [TBL] [Abstract][Full Text] [Related]
9. Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases. van Engelen ME; Heijst H; Willemse EAJ; Oudega ML; Vermunt L; Scheltens P; Vijverberg EGB; Pijnenburg YAL; Teunissen CE Brain Commun; 2023; 5(2):fcad120. PubMed ID: 37101834 [No Abstract] [Full Text] [Related]
10. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction. Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126 [TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies. Mariotto S; Farinazzo A; Magliozzi R; Alberti D; Monaco S; Ferrari S J Peripher Nerv Syst; 2018 Sep; 23(3):174-177. PubMed ID: 29974556 [TBL] [Abstract][Full Text] [Related]
12. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388 [TBL] [Abstract][Full Text] [Related]
13. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists? Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of serum neurofilament light chains levels for diagnosis, treatment monitoring and prognosis in multiple sclerosis]. Alifirova VM; Kamenskikh EM; Koroleva ES Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):7-13. PubMed ID: 31934983 [TBL] [Abstract][Full Text] [Related]